chr1_-_86043932
|
2.621
|
NM_001134445
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
chr1_-_85930733
|
2.597
|
NM_012137
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
chr7_-_47621741
|
2.244
|
NM_022748
|
TNS3
|
tensin 3
|
chr12_-_106533810
|
2.231
|
NM_014840
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
chr3_-_145879222
|
2.184
|
NM_000935
NM_182943
|
PLOD2
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
|
chr2_-_216300770
|
1.884
|
NM_002026
NM_054034
NM_212474
NM_212476
NM_212478
NM_212482
|
FN1
|
fibronectin 1
|
chr1_-_94703252
|
1.813
|
NM_004815
|
ARHGAP29
|
Rho GTPase activating protein 29
|
chr3_-_32023237
|
1.717
|
NM_001174060
NM_017784
|
OSBPL10
|
oxysterol binding protein-like 10
|
chr2_+_235860616
|
1.671
|
NM_014521
|
SH3BP4
|
SH3-domain binding protein 4
|
chr3_-_134093235
|
1.495
|
NM_016201
|
AMOTL2
|
angiomotin like 2
|
chr13_-_107187312
|
1.357
|
NM_004093
|
EFNB2
|
ephrin-B2
|
chr2_-_227663454
|
1.335
|
NM_005544
|
IRS1
|
insulin receptor substrate 1
|
chr2_+_46524448
|
1.175
|
NM_001430
|
EPAS1
|
endothelial PAS domain protein 1
|
chr8_-_11725628
|
1.112
|
NM_001908
NM_147780
NM_147781
NM_147782
NM_147783
|
CTSB
|
cathepsin B
|
chr8_-_125740650
|
1.081
|
NM_014751
|
MTSS1
|
metastasis suppressor 1
|
chr11_+_69455837
|
1.069
|
NM_053056
|
CCND1
|
cyclin D1
|
chr1_+_182992329
|
1.063
|
NM_002293
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
chr9_-_107690526
|
1.054
|
NM_005502
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
chr1_-_209979388
|
1.017
|
NM_001206696
NM_006147
|
IRF6
|
interferon regulatory factor 6
|
chr8_-_134309448
|
0.984
|
NM_001135242
NM_006096
|
NDRG1
|
N-myc downstream regulated 1
|
chr20_-_50384899
|
0.982
|
NM_006045
|
ATP9A
|
ATPase, class II, type 9A
|
chr3_-_16555128
|
0.974
|
NM_015150
|
RFTN1
|
raftlin, lipid raft linker 1
|
chr20_-_56286540
|
0.965
|
NM_199171
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
chr16_+_8768403
|
0.965
|
NM_020686
|
ABAT
|
4-aminobutyrate aminotransferase
|
chr4_+_78078332
|
0.952
|
NM_004354
|
CCNG2
|
cyclin G2
|
chr10_-_15413054
|
0.950
|
NM_001010924
|
FAM171A1
|
family with sequence similarity 171, member A1
|
chr3_+_187943192
|
0.945
|
NM_001167671
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
chr1_-_20812727
|
0.944
|
NM_018584
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
chr7_+_98246595
|
0.935
|
NM_002523
|
NPTX2
|
neuronal pentraxin II
|
chr3_+_187871473
|
0.928
|
NM_001167672
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
chr21_+_18885104
|
0.901
|
NM_001207063
NM_001207064
NM_001207065
NM_001207066
NM_001338
|
CXADR
|
coxsackie virus and adenovirus receptor
|
chr12_-_124457099
|
0.883
|
NM_025140
|
CCDC92
|
coiled-coil domain containing 92
|
chr10_+_114709963
|
0.880
|
NM_001146274
NM_001146283
NM_001146284
NM_001146285
NM_001146286
NM_001198525
NM_001198526
NM_001198527
NM_001198528
NM_001198529
NM_001198530
NM_001198531
NM_030756
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
chr7_+_17338182
|
0.875
|
NM_001621
|
AHR
|
aryl hydrocarbon receptor
|
chr2_-_151344145
|
0.870
|
NM_005168
|
RND3
|
Rho family GTPase 3
|
chr3_+_187930720
|
0.867
|
NM_005578
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
chr16_+_8814567
|
0.849
|
NM_001127448
|
ABAT
|
4-aminobutyrate aminotransferase
|
chr1_-_154946859
|
0.814
|
NM_001130041
NM_001202859
NM_003029
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
chr6_-_169654047
|
0.811
|
NM_003247
|
THBS2
|
thrombospondin 2
|
chr18_+_47088400
|
0.807
|
NM_006033
|
LIPG
|
lipase, endothelial
|
chr4_-_114900802
|
0.804
|
NM_024590
|
ARSJ
|
arylsulfatase family, member J
|
chr7_-_111846384
|
0.800
|
NM_014705
|
DOCK4
|
dedicator of cytokinesis 4
|
chr19_-_45909566
|
0.798
|
NM_001142502
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
chr5_-_172756505
|
0.785
|
NM_003714
|
STC2
|
stanniocalcin 2
|
chr3_+_135741576
|
0.781
|
NM_181897
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha
|
chr10_-_62703822
|
0.778
|
NM_001242359
NM_014836
|
RHOBTB1
|
Rho-related BTB domain containing 1
|
chr3_+_135684463
|
0.770
|
NM_001190447
NM_002718
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha
|
chr2_+_241375030
|
0.764
|
NM_002081
|
GPC1
|
glypican 1
|
chr10_+_129705299
|
0.752
|
NM_006504
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
chr12_+_78225068
|
0.747
|
NM_014903
|
NAV3
|
neuron navigator 3
|
chr14_+_65007163
|
0.745
|
NM_021979
|
HSPA2
|
heat shock 70kDa protein 2
|
chr15_+_99192696
|
0.738
|
NM_000875
|
IGF1R
|
insulin-like growth factor 1 receptor
|
chr4_-_102268626
|
0.717
|
NM_000944
NM_001130691
NM_001130692
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
chr20_-_56285576
|
0.704
|
NM_199169
NM_199170
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
chr2_-_235405692
|
0.703
|
NM_005737
|
ARL4C
|
ADP-ribosylation factor-like 4C
|
chr7_-_131241321
|
0.699
|
NM_001018111
NM_005397
|
PODXL
|
podocalyxin-like
|
chr9_+_137533643
|
0.698
|
NM_000093
|
COL5A1
|
collagen, type V, alpha 1
|
chr3_-_57113292
|
0.696
|
NM_001128615
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
chr2_+_85360373
|
0.695
|
NM_031283
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
chr20_-_56284945
|
0.688
|
NM_020182
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
chr2_-_158732341
|
0.673
|
NM_001111067
|
ACVR1
|
activin A receptor, type I
|
chr14_+_105331581
|
0.671
|
NM_001112726
NM_015005
|
KIAA0284
|
KIAA0284
|
chr19_-_45908288
|
0.669
|
NM_006663
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
chr17_-_1389013
|
0.662
|
NM_001080950
|
MYO1C
|
myosin IC
|
chr10_+_129845806
|
0.661
|
NM_130435
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
chr8_-_122653493
|
0.656
|
NM_005328
|
HAS2
|
hyaluronan synthase 2
|
chr16_+_8806825
|
0.655
|
NM_000663
|
ABAT
|
4-aminobutyrate aminotransferase
|
chr5_-_139726173
|
0.646
|
NM_001945
|
HBEGF
|
heparin-binding EGF-like growth factor
|
chr17_-_1395950
|
0.644
|
NM_001080779
|
MYO1C
|
myosin IC
|
chr5_+_17217474
|
0.638
|
NM_006317
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
chr3_+_138066489
|
0.628
|
NM_001252091
NM_012219
|
MRAS
|
muscle RAS oncogene homolog
|
chr17_-_1394849
|
0.617
|
NM_033375
|
MYO1C
|
myosin IC
|
chr3_-_56809594
|
0.612
|
NM_001128616
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
chr9_+_79093256
|
0.610
|
NM_001097635
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
chr1_+_9352931
|
0.610
|
NM_025106
|
SPSB1
|
splA/ryanodine receptor domain and SOCS box containing 1
|
chr3_-_57583153
|
0.608
|
NM_001660
|
ARF4
|
ADP-ribosylation factor 4
|
chr5_+_86564044
|
0.608
|
NM_002890
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
chr4_+_146403955
|
0.606
|
NM_001003688
|
SMAD1
|
SMAD family member 1
|
chr2_+_102314162
|
0.598
|
NM_001242560
NM_004834
NM_145686
NM_001242559
NM_145687
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
chr17_-_41174431
|
0.588
|
NM_006373
|
VAT1
|
vesicle amine transport protein 1 homolog (T. californica)
|
chr10_+_128593994
|
0.587
|
NM_001380
|
DOCK1
|
dedicator of cytokinesis 1
|
chr8_+_123793894
|
0.582
|
NM_014943
|
ZHX2
|
zinc fingers and homeoboxes 2
|
chr4_+_146402704
|
0.578
|
NM_005900
|
SMAD1
|
SMAD family member 1
|
chr8_+_56015013
|
0.575
|
NM_052898
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4
|
chr11_+_12695851
|
0.575
|
NM_021961
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
chr3_+_179370779
|
0.572
|
NM_003940
|
USP13
|
ubiquitin specific peptidase 13 (isopeptidase T-3)
|
chrX_-_106960268
|
0.571
|
NM_004089
|
TSC22D3
|
TSC22 domain family, member 3
|
chr5_+_86564727
|
0.570
|
NM_022650
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
chrX_-_107019001
|
0.568
|
NM_198057
|
TSC22D3
|
TSC22 domain family, member 3
|
chr17_+_66508098
|
0.566
|
NM_212471
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
chr11_+_844445
|
0.550
|
NM_001025237
|
TSPAN4
|
tetraspanin 4
|
chr10_+_63661012
|
0.544
|
NM_032199
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
chr2_-_158731622
|
0.537
|
NM_001105
|
ACVR1
|
activin A receptor, type I
|
chr5_+_52776263
|
0.535
|
NM_006350
NM_013409
|
FST
|
follistatin
|
chr9_+_36036900
|
0.535
|
NM_021111
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
chr9_+_79115548
|
0.534
|
NM_001097636
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
chr1_+_82266081
|
0.529
|
NM_012302
|
LPHN2
|
latrophilin 2
|
chr2_-_230135954
|
0.524
|
NM_001100818
NM_017933
|
PID1
|
phosphotyrosine interaction domain containing 1
|
chr11_-_89224413
|
0.524
|
NM_001143836
NM_016931
|
NOX4
|
NADPH oxidase 4
|
chr11_-_115375065
|
0.520
|
NM_001098517
NM_014333
|
CADM1
|
cell adhesion molecule 1
|
chr17_+_66508525
|
0.513
|
NM_002734
NM_212472
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
chr1_+_7831326
|
0.511
|
NM_004781
|
VAMP3
|
vesicle-associated membrane protein 3 (cellubrevin)
|
chr2_+_201170603
|
0.510
|
NM_015535
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
chr3_-_56835829
|
0.509
|
NM_019555
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
chr9_+_19049355
|
0.507
|
NM_006570
|
RRAGA
|
Ras-related GTP binding A
|
chr3_-_46037299
|
0.506
|
NM_024513
|
FYCO1
|
FYVE and coiled-coil domain containing 1
|
chrX_-_133119624
|
0.505
|
NM_001164617
NM_001164618
NM_001164619
NM_004484
|
GPC3
|
glypican 3
|
chr9_+_79056581
|
0.503
|
NM_001097634
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
chr1_-_154943001
|
0.497
|
NM_001130040
NM_183001
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
chr11_+_842821
|
0.494
|
NM_001025238
NM_001025239
NM_003271
NM_001025235
NM_001025236
|
TSPAN4
|
tetraspanin 4
|
chr1_-_95392501
|
0.493
|
NM_001839
|
CNN3
|
calponin 3, acidic
|
chr21_-_44846927
|
0.493
|
NM_173354
|
SIK1
|
salt-inducible kinase 1
|
chr17_+_2699731
|
0.492
|
NM_001100398
NM_015085
|
RAP1GAP2
|
RAP1 GTPase activating protein 2
|
chr1_-_236228476
|
0.490
|
NM_002508
|
NID1
|
nidogen 1
|
chr11_-_89322778
|
0.482
|
NM_001143837
|
NOX4
|
NADPH oxidase 4
|
chr7_-_22396511
|
0.479
|
NM_012294
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5
|
chr15_-_23086290
|
0.478
|
NM_144599
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
chr13_-_41240607
|
0.476
|
NM_002015
|
FOXO1
|
forkhead box O1
|
chr3_+_57994087
|
0.472
|
NM_001164317
NM_001164318
NM_001164319
NM_001457
|
FLNB
|
filamin B, beta
|
chr11_+_844062
|
0.469
|
NM_001025234
|
TSPAN4
|
tetraspanin 4
|
chr3_-_87040246
|
0.458
|
NM_016206
|
VGLL3
|
vestigial like 3 (Drosophila)
|
chrX_-_153141398
|
0.458
|
NM_000425
NM_001143963
NM_024003
|
L1CAM
|
L1 cell adhesion molecule
|
chr2_+_201170795
|
0.455
|
NM_001100422
NM_001100424
NM_001100423
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
chr1_+_26606212
|
0.449
|
NM_031286
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3
|
chr2_-_73340073
|
0.447
|
NM_015470
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I)
|
chr20_+_9288446
|
0.442
|
NM_000933
|
PLCB4
|
phospholipase C, beta 4
|
chr8_+_97505876
|
0.441
|
NM_002998
|
SDC2
|
syndecan 2
|
chr14_+_23340955
|
0.435
|
NM_014045
|
LRP10
|
low density lipoprotein receptor-related protein 10
|
chr13_+_98795410
|
0.430
|
NM_001001715
NM_005766
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
chr1_+_192778168
|
0.428
|
NM_002923
|
RGS2
|
regulator of G-protein signaling 2, 24kDa
|
chr6_-_112194648
|
0.424
|
NM_002037
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
chr14_-_89883306
|
0.422
|
NM_005197
|
FOXN3
|
forkhead box N3
|
chr20_+_9198036
|
0.417
|
NM_182797
|
PLCB4
|
phospholipase C, beta 4
|
chr7_+_94285620
|
0.415
|
NM_001040152
NM_001184961
NM_001184962
NM_015068
|
PEG10
|
paternally expressed 10
|
chr2_-_218808705
|
0.413
|
NM_022648
|
TNS1
|
tensin 1
|
chr16_+_69220940
|
0.405
|
NM_006750
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)
|
chr11_-_17191287
|
0.404
|
NM_002645
|
PIK3C2A
|
phosphoinositide-3-kinase, class 2, alpha polypeptide
|
chr18_-_5543967
|
0.400
|
NM_012307
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
chr12_-_49177876
|
0.395
|
NM_015270
|
ADCY6
|
adenylate cyclase 6
|
chr6_-_112080284
|
0.393
|
NM_153048
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
chr8_+_102504661
|
0.392
|
NM_024915
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
chr7_+_94285676
|
0.392
|
NM_001172437
NM_001172438
|
PEG10
|
paternally expressed 10
|
chr6_-_52441815
|
0.384
|
NM_012288
|
TRAM2
|
translocation associated membrane protein 2
|
chrX_+_9983793
|
0.381
|
NM_015691
|
WWC3
|
WWC family member 3
|
chr11_+_76494132
|
0.376
|
NM_015516
|
TSKU
|
tsukushi small leucine rich proteoglycan homolog (Xenopus laevis)
|
chr6_-_112041253
|
0.375
|
NM_153047
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
chr20_+_9049660
|
0.375
|
NM_001172646
|
PLCB4
|
phospholipase C, beta 4
|
chr3_+_37903643
|
0.372
|
NM_001008392
NM_005808
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
chr18_+_56530060
|
0.369
|
NM_018181
|
ZNF532
|
zinc finger protein 532
|
chr8_-_57906423
|
0.366
|
NM_017813
|
IMPAD1
|
inositol monophosphatase domain containing 1
|
chr16_-_52581713
|
0.366
|
NM_001146188
|
TOX3
|
TOX high mobility group box family member 3
|
chr3_-_66550844
|
0.365
|
NM_015541
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
chr6_+_31126114
|
0.363
|
NM_001077511
NM_007109
|
TCF19
|
transcription factor 19
|
chrY_+_16635625
|
0.355
|
NM_014893
|
NLGN4Y
|
neuroligin 4, Y-linked
|
chr16_-_52580805
|
0.354
|
NM_001080430
|
TOX3
|
TOX high mobility group box family member 3
|
chrX_-_6145887
|
0.350
|
NM_020742
|
NLGN4X
|
neuroligin 4, X-linked
|
chr17_+_21191347
|
0.347
|
NM_002756
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
chr10_+_104613966
|
0.342
|
NM_001136200
NM_144591
|
C10orf32-AS3MT
C10orf32
|
C10orf32-AS3MT readthrough
chromosome 10 open reading frame 32
|
chr22_+_30792929
|
0.341
|
NM_001204204
NM_012429
NM_033382
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
chr10_-_16859408
|
0.339
|
NM_012425
NM_152724
|
RSU1
|
Ras suppressor protein 1
|
chr10_-_101945787
|
0.337
|
NM_001100626
|
ERLIN1
|
ER lipid raft associated 1
|
chr11_-_79151694
|
0.336
|
NM_001098816
|
ODZ4
|
odz, odd Oz/ten-m homolog 4 (Drosophila)
|
chr12_+_3186520
|
0.331
|
NM_001168320
NM_006675
|
TSPAN9
|
tetraspanin 9
|
chr17_+_25621105
|
0.327
|
NM_015626
NM_134265
|
WSB1
|
WD repeat and SOCS box containing 1
|
chr8_-_119123804
|
0.325
|
NM_000127
|
EXT1
|
exostosin 1
|
chrX_-_48931645
|
0.320
|
NM_007213
|
PRAF2
|
PRA1 domain family, member 2
|
chr11_+_121163501
|
0.320
|
NM_001024956
|
SC5DL
|
sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like
|
chr17_+_68165660
|
0.319
|
NM_000891
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2
|
chr18_+_11851388
|
0.318
|
NM_020412
|
CHMP1B
|
charged multivesicular body protein 1B
|
chr6_+_30034931
|
0.317
|
NM_021959
|
PPP1R11
|
protein phosphatase 1, regulatory (inhibitor) subunit 11
|
chr10_-_70287249
|
0.314
|
NM_152707
|
SLC25A16
|
solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16
|
chr1_+_205473683
|
0.313
|
NM_002596
NM_212502
NM_212503
|
CDK18
|
cyclin-dependent kinase 18
|
chr19_-_14606939
|
0.312
|
NM_005716
NM_202467
NM_202468
NM_202469
NM_202470
NM_202494
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
chr4_+_3768295
|
0.309
|
NM_000683
|
ADRA2C
|
adrenergic, alpha-2C-, receptor
|
chr17_-_4851797
|
0.305
|
NM_005022
|
PFN1
|
profilin 1
|
chr6_-_6320897
|
0.303
|
NM_000129
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
chrY_+_16634487
|
0.302
|
NM_001206850
|
NLGN4Y
|
neuroligin 4, Y-linked
|
chr12_-_118541655
|
0.302
|
NM_019086
|
VSIG10
|
V-set and immunoglobulin domain containing 10
|
chr6_-_6007632
|
0.300
|
NM_016588
|
NRN1
|
neuritin 1
|
chr1_+_155100304
|
0.300
|
NM_004428
NM_182685
|
EFNA1
|
ephrin-A1
|
chr6_-_16761600
|
0.297
|
NM_000332
NM_001128164
|
ATXN1
|
ataxin 1
|
chr14_+_64680858
|
0.296
|
NM_182913
|
SYNE2
|
spectrin repeat containing, nuclear envelope 2
|
chr9_+_79074067
|
0.294
|
NM_001097633
NM_001490
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
chr1_-_109584589
|
0.292
|
NM_001142550
NM_001142551
NM_014969
|
WDR47
|
WD repeat domain 47
|
chr7_-_51384458
|
0.286
|
NM_015198
|
COBL
|
cordon-bleu homolog (mouse)
|
chr18_-_46475702
|
0.284
|
NM_001190822
|
SMAD7
|
SMAD family member 7
|
chrX_-_102941582
|
0.281
|
NM_001142418
NM_001142423
NM_001142424
NM_001142425
NM_001142426
NM_001142429
NM_001142430
NM_012286
|
MORF4L2
|
mortality factor 4 like 2
|
chr10_+_71561643
|
0.280
|
NM_001130103
NM_080798
NM_080800
NM_080801
NM_080802
NM_080805
|
COL13A1
|
collagen, type XIII, alpha 1
|
chr10_-_32345337
|
0.279
|
NM_004521
|
KIF5B
|
kinesin family member 5B
|
chr16_-_48644087
|
0.277
|
NM_153029
|
N4BP1
|
NEDD4 binding protein 1
|
chr3_+_39851028
|
0.275
|
NM_015460
|
MYRIP
|
myosin VIIA and Rab interacting protein
|
chr17_+_36507708
|
0.274
|
NM_014598
|
SOCS7
|
suppressor of cytokine signaling 7
|
chr1_+_203595897
|
0.270
|
NM_001001396
NM_001684
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
chr17_-_80231560
|
0.268
|
NM_001893
NM_139062
|
CSNK1D
|
casein kinase 1, delta
|
chr12_+_51632507
|
0.268
|
NM_001136264
NM_001136266
NM_001136267
NM_001136268
NM_001136269
NM_014764
|
DAZAP2
|
DAZ associated protein 2
|
chr2_-_96931744
|
0.267
|
NM_001193304
NM_017849
|
TMEM127
|
transmembrane protein 127
|
chr14_+_69865380
|
0.265
|
NM_001252148
NM_001252150
NM_018375
|
SLC39A9
|
solute carrier family 39 (zinc transporter), member 9
|
chr10_-_101945686
|
0.262
|
NM_006459
|
ERLIN1
|
ER lipid raft associated 1
|
chr5_-_157002739
|
0.262
|
NM_033274
|
ADAM19
|
ADAM metallopeptidase domain 19
|
chr20_+_11871364
|
0.261
|
NM_181443
|
BTBD3
|
BTB (POZ) domain containing 3
|